786 related articles for article (PubMed ID: 26775730)
1. The Wnt signaling pathway in cancer.
Duchartre Y; Kim YM; Kahn M
Crit Rev Oncol Hematol; 2016 Mar; 99():141-9. PubMed ID: 26775730
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells.
Duchartre Y; Kim YM; Kahn M
Methods Mol Biol; 2017; 1613():463-478. PubMed ID: 28849572
[TBL] [Abstract][Full Text] [Related]
3. Wnt Signaling in Stem Cells and Tumor Stem Cells.
Kahn M
Semin Reprod Med; 2015 Sep; 33(5):317-25. PubMed ID: 26251120
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms promoting physiological cells progression into tumorigenesis.
Korbut E; Ptak-Belowska A; Brzozowski T
J Physiol Pharmacol; 2012 Dec; 63(6):565-70. PubMed ID: 23388471
[TBL] [Abstract][Full Text] [Related]
5. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
[TBL] [Abstract][Full Text] [Related]
6. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
[TBL] [Abstract][Full Text] [Related]
7. A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway.
Liu S; Gao X; Zhang L; Qin S; Wei M; Liu N; Zhao R; Li B; Meng Y; Lin G; Lu C; Liu X; Xie M; Liu T; Zhou H; Qi M; Yang G; Yang C
Eur J Med Chem; 2018 Aug; 156():21-42. PubMed ID: 30006166
[TBL] [Abstract][Full Text] [Related]
8. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells.
Zhu J; Jiang Y; Yang X; Wang S; Xie C; Li X; Li Y; Chen Y; Wang X; Meng Y; Zhu M; Wu R; Huang C; Ma X; Geng S; Wu J; Zhong C
Biochem Biophys Res Commun; 2017 Jan; 482(1):15-21. PubMed ID: 27836540
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
10. Understanding the cancer stem cell phenotype: A step forward in the therapeutic management of cancer.
Wong ALA; Bellot GL; Hirpara JL; Pervaiz S
Biochem Pharmacol; 2019 Apr; 162():79-88. PubMed ID: 30689981
[TBL] [Abstract][Full Text] [Related]
11. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
Song L; Li Y; He B; Gong Y
Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
[TBL] [Abstract][Full Text] [Related]
12. Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer.
Dwivedi AR; Thakur A; Kumar V; Skvortsova I; Kumar V
Curr Drug Targets; 2020; 21(3):258-278. PubMed ID: 31433755
[TBL] [Abstract][Full Text] [Related]
13. The Delivery of a Wnt Pathway Inhibitor Toward CSCs Requires Stable Liposome Encapsulation and Delayed Drug Release in Tumor Tissues.
Li C; Liang Y; Cao J; Zhang N; Wei X; Tu M; Xu F; Xu Y
Mol Ther; 2019 Sep; 27(9):1558-1567. PubMed ID: 31350188
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.
Tabatabai R; Linhares Y; Bolos D; Mita M; Mita A
Target Oncol; 2017 Oct; 12(5):623-641. PubMed ID: 28653295
[TBL] [Abstract][Full Text] [Related]
15. Wnt signaling in cancer.
Zhan T; Rindtorff N; Boutros M
Oncogene; 2017 Mar; 36(11):1461-1473. PubMed ID: 27617575
[TBL] [Abstract][Full Text] [Related]
16. Drug discovery approaches to target Wnt signaling in cancer stem cells.
Curtin JC; Lorenzi MV
Oncotarget; 2010 Nov; 1(7):563-577. PubMed ID: 21317452
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.
Deng S; Wong CKC; Lai HC; Wong AST
Oncotarget; 2017 Apr; 8(16):25897-25914. PubMed ID: 27825116
[TBL] [Abstract][Full Text] [Related]
18. Sonic hedgehog and Wnt/β-catenin pathways mediate curcumin inhibition of breast cancer stem cells.
Li X; Wang X; Xie C; Zhu J; Meng Y; Chen Y; Li Y; Jiang Y; Yang X; Wang S; Chen J; Zhang Q; Geng S; Wu J; Zhong C; Zhao Y
Anticancer Drugs; 2018 Mar; 29(3):208-215. PubMed ID: 29356693
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells - A therapeutic target?
Maitland NJ; Collins AT
Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
[TBL] [Abstract][Full Text] [Related]
20. [Progress in the study of targeted drug delivery systems for cancer stem cells].
Qiao MX; Zhang XJ; Shuang BA; Hu HY; Zhao XL; Chen DW
Yao Xue Xue Bao; 2013 Apr; 48(4):477-83. PubMed ID: 23833932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]